Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | November 03, 2023 09:05am

Gainers

  • Novo Integrated Sciences (NASDAQ:NVOS) stock moved upwards by 25.6% to $0.32 during Friday's pre-market session. The company's market cap stands at $54.5 million.
  • Werewolf Therapeutics (NASDAQ:HOWL) shares rose 20.0% to $2.58. The company's market cap stands at $91.9 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) stock rose 16.93% to $0.37. The market value of their outstanding shares is at $7.7 million.
  • Altamira Therapeutics (NASDAQ:CYTO) shares moved upwards by 14.98% to $0.19. The company's market cap stands at $1.4 million.
  • Arcutis Biotherapeutics (NASDAQ:ARQT) shares moved upwards by 13.96% to $2.53. The market value of their outstanding shares is at $238.2 million. As per the press release, Q3 earnings came out today.
  • CVRx (NASDAQ:CVRX) stock moved upwards by 13.8% to $15.5. The market value of their outstanding shares is at $322.6 million.

Losers

  • Panbela Therapeutics (NASDAQ:PBLA) stock fell 30.5% to $0.66 during Friday's pre-market session. The market value of their outstanding shares is at $1.9 million.
  • NexImmune (NASDAQ:NEXI) shares decreased by 28.75% to $2.65. The market value of their outstanding shares is at $2.8 million.
  • Agilon Health (NYSE:AGL) shares fell 14.04% to $14.52. The company's market cap stands at $5.8 billion. As per the news, the Q3 earnings report came out yesterday.
  • Erasca (NASDAQ:ERAS) shares declined by 12.06% to $2.07. The company's market cap stands at $312.1 million.
  • Turnstone Biologics (NASDAQ:TSBX) shares decreased by 11.86% to $2.9. The company's market cap stands at $66.2 million.
  • AbCellera Biologics (NASDAQ:ABCL) shares declined by 10.16% to $3.98. The market value of their outstanding shares is at $1.1 billion. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ABCL AGL ARQT CVRX CYTO ERAS HOWL KTTA NEXI NVOS PBLA TSBX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist